Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03GWA
|
||||
| Former ID |
DNC011326
|
||||
| Drug Name |
NSC-669977
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C16H16N4
|
||||
| Canonical SMILES |
CN1CC(=CC2=C1C=CC(=C2N=N)N)C3=CC=CC=C3
|
||||
| InChI |
1S/C16H16N4/c1-20-10-12(11-5-3-2-4-6-11)9-13-15(20)8-7-14(17)16(13)19-18/h2-9,18H,10,17H2,1H3
|
||||
| InChIKey |
VZQKWRKRDCBNCA-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | NRH dehydrogenase [quinone] 2 | Target Info | Inhibitor | [1] | |
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. Epub 2010 Oct 21.In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.